The effectiveness of the CoronaVac vaccine from SinovaŃ Biotech in the country affected by the “Brazilian” strain of coronavirus after two doses reaches only 42% protection against COVID-19 with symptoms. We are talking about the effectiveness in the elderly from 70 years and older, write in the preprint of the study on medRxiv. For […]
Tag: preprint
Effectiveness of Moderna and Pfizer-BNT Against Symptoms and Hospitalization: First Estimates from the USA
American doctors have assessed the effectiveness of Moderna and Pfizer-BNT RNA vaccinations in preventing COVID-19 symptoms no longer in clinical trials, but in real conditions of mass vaccination of the US population. A preprint (not yet peer reviewed report) is available on medRxiv. The report was compiled by experts from the Mayo Clinic network using […]
This is phase IV. The first data on the Pfizer-BioNTech vaccine have appeared in Israel
In Israel, for the first time, the ability of the Pfizer-BioNTech anticoid vaccine to induce an immune response was evaluated three weeks after the first dose, that is, before the fixing (second) injection. The results for the population at high risk of catching the coronavirus – for medical professionals – are published as a preprint […]